Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study. Topp MS, Matasar M, Allan JN, Ansell SM, et al. Blood 2025;145:1498-1509.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Topp MS, Matasar M, Allan JN, Ansell SM, et al. Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study. Blood 2025;145:1498-1509.
PMID: 39786390